Our Perspectives
THREAD Blog
Factors Shaping Study Timelines: Screenshots, Localized Content, and the Complex Role of IRB Submission Timing
Imagine a time when Sponsors and CROS can manage the study submission process without any dependencies on external parties. Having part of a process dependent on external parties adds risk and undue pressure on all parties and ultimately impacts patients who are waiting for the treatments that are to be tested.
3 Considerations for Creating a Patient-First eCOA Solution
Researchers are working hard to create more accessible activities (think inputs) for patients so they can get in and get out quickly - but what if we did both? Unfortunately, it's not as simple as it sounds but the reality is any truly functional eCOA strategy will require a creative approach to both inputs and processes. Here are three ways you can get started on your journey of putting the patient first in your eCOA.
The Benefits of Using eCOA in Clinical Trials
eCOAs are not new, but despite being recommended by regulatory authorities like the U.S FDA, many study teams still choose to collect assessment data with pen and paper. Find out why paper COAs add unnecessary risk, especially with trials becoming more advanced and the industry acknowledging the need to reach more diverse and widely dispersed populations of patients.
Enhancing Patient Engagement with eCOA
One aspect of study design to consider when building better research experiences for patients is a genuinely patient-centered eCOA program. Here are some tips for ensuring that your eCOA is built with the needs of patients in mind and able to deliver the kind of engagement necessary for successful trials.
How eCOA Improves Patient Experience
It is critical to ensure clinical trials are truly patient-centered. Although the intention to incorporate patient input and feedback can be seen throughout the clinical research industry, clinical research studies often don’t rise to that challenge. Find out how eCOA can improve patient experience in clinical trials.